People & Business :: Emerging Companies
BioAmber Closes Series B Funding Round
2:23 PM MDT | May 5, 2011 | Vincent Valk
BioAmber (Minneapolis), a maker of biobased succinic and adipic acid, has completed a Series B funding round, raising $45 million. Naxos Capital Partners (Luxembourg), a venture capital firm, led the round, which was joined by Mitsui's venture capital arm. Mitsui & Co. announced a succinic acid supply agreement with BioAmber late last month. The round will fund construction of a major biosuccinic acid plant in North America and fund continued development work, including a license from DuPont on making 1,4-butanediol from succinic acid. The company's Series A...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee